QT
APEN

Quantbot Technologies’s Apollo Endosurgery, Inc. APEN Stock Holding History

Quantbot Technologies’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,125
Closed -$241K – 2217
2022
Q4 		$241K Buy
+24,125
New +$180K 0.02% 829

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Quantbot Technologies's APEN Position: Q1 2023 in Review

Quantbot Technologies sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 24,125 shares — an estimated $241K sold.

Quantbot Technologies first reported a position in APEN in Q4 2022 and held it in 1 quarter. The position peaked at $241K in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Quantbot Technologies reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 24,125 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $241K.
  • Quantbot Technologies first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 1 quarter.
  • Quantbot Technologies's Apollo Endosurgery, Inc. position peaked at $241K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.